ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,211Medicare Part D Prescriptions Filled, Including Refills

Rank: 208 out of 939

$590K Total Retail Price of All Prescriptions

Rank: 181 out of 939

495 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 495 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 495 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 9,884 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
PRAVASTATIN SODIUM 499 446 1 13
AMLODIPINE BESYLATE 433 392 2 6
OMEPRAZOLE 410 338 3 5
LEVOTHYROXINE SODIUM 398 366 4 4
FUROSEMIDE 346 331 5 7
POTASSIUM CHLORIDE 332 322 6 9
ENALAPRIL MALEATE 226 189 7 65
HYDROCHLOROTHIAZIDE 214 208 8 12
ATORVASTATIN CALCIUM 198 186 9 22
LISINOPRIL 198 195 9 3
METOPROLOL TARTRATE 196 170 11 10
METFORMIN HCL 193 135 12 8
SERTRALINE HCL 192 153 13 24
ALENDRONATE SODIUM 191 174 14 40
GABAPENTIN 176 141 15 11
CITALOPRAM HBR 165 142 16 15
WARFARIN SODIUM 164 127 17 17
TRAMADOL HCL 138 96 18 16
RANITIDINE HCL 126 103 19 35
BENAZEPRIL HCL 119 103 20 87
CLOPIDOGREL 118 112 21 28
PLAVIX 118 109 21 48
CARVEDILOL 116 115 23 25
ATENOLOL 112 112 24 19
HYDROCODONE-ACETAMINOPHEN 109 91 S3 25 1
DONEPEZIL HCL 105 101 26 30
CRESTOR 102 81 27 34
DILTIAZEM 24HR CD 102 102 27 126
TRAZODONE HCL 101 84 29 26
DIOVAN 101 88 29 50
METOPROLOL SUCCINATE 100 90 31 21
NAMENDA 98 94 32 49
ALLOPURINOL 95 93 33 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 75 34 23
GLIMEPIRIDE 89 85 35 37
MELOXICAM 87 66 36 14
FLUOXETINE HCL 85 62 37 47
CARBIDOPA-LEVODOPA 82 82 38 102
LOSARTAN POTASSIUM 79 77 39 29
PREDNISONE 78 62 40 42
ISOSORBIDE MONONITRATE ER 71 60 41 53
TAMSULOSIN HCL 70 70 42 27
FENOFIBRATE 70 50 42 83
NEXIUM 68 68 44 18
LOSARTAN-HYDROCHLOROTHIAZIDE 67 61 45 55
LOVASTATIN 64 54 46 46
VESICARE 59 57 47 202
ATENOLOL-CHLORTHALIDONE 59 49 47 164
FLUTICASONE PROPIONATE 59 42 47 43
PREMARIN 57 49 R 50 111
SPIRONOLACTONE 56 56 51 71
NAPROXEN 56 52 51 72
DIVALPROEX SODIUM 55 40 53 95
SOTALOL 54 54 54 252
ZOLPIDEM TARTRATE 53 52 55 20
INSULIN SYRINGE 50 44 56 97
PANTOPRAZOLE SODIUM 50 44 56 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.